Chemoinformaics analysis of (+)-6-Acetylcorynoline
| Molecular Weight | 409.438 | nRot | 1 |
| Heavy Atom Molecular Weight | 386.254 | nRig | 30 |
| Exact Molecular Weight | 409.153 | nRing | 6 |
| Solubility: LogS | -4.009 | nHRing | 3 |
| Solubility: LogP | 3.043 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 59.6582 |
| nHD | 0 | BPOL | 34.3318 |
| QED | 0.671 |
| Synth | 4.095 |
| Natural Product Likeliness | 1.916 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.191 |
| Pgp-sub | 0.007 |
| HIA | 0.002 |
| CACO-2 | -5.018 |
| MDCK | 0.0000326 |
| BBB | 0.927 |
| PPB | 0.951076 |
| VDSS | 2.635 |
| FU | 0.0426431 |
| CYP1A2-inh | 0.833 |
| CYP1A2-sub | 0.154 |
| CYP2c19-inh | 0.91 |
| CYP2c19-sub | 0.93 |
| CYP2c9-inh | 0.06 |
| CYP2c9-sub | 0.836 |
| CYP2d6-inh | 0.985 |
| CYP2d6-sub | 0.91 |
| CYP3a4-inh | 0.941 |
| CYP3a4-sub | 0.911 |
| CL | 14.782 |
| T12 | 0.139 |
| hERG | 0.011 |
| Ames | 0.055 |
| ROA | 0.24 |
| SkinSen | 0.159 |
| Carcinogencity | 0.847 |
| EI | 0.092 |
| Respiratory | 0.895 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.752364 |